347 related articles for article (PubMed ID: 11072063)
41. NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.
Maris C; Masse J; Chester A; Navaratnam N; Allain FH
RNA; 2005 Feb; 11(2):173-86. PubMed ID: 15659357
[TBL] [Abstract][Full Text] [Related]
42. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.
Hersberger M; Innerarity TL
J Biol Chem; 1998 Apr; 273(16):9435-42. PubMed ID: 9545269
[TBL] [Abstract][Full Text] [Related]
43. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
Severi F; Chicca A; Conticello SG
Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
[TBL] [Abstract][Full Text] [Related]
44. Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker.
Lellek H; Welker S; Diehl I; Kirsten R; Greeve J
J Biol Chem; 2002 Jun; 277(26):23638-44. PubMed ID: 11976346
[TBL] [Abstract][Full Text] [Related]
45. Specific 3' sequences flanking a minimal apolipoprotein B (apoB) mRNA editing 'cassette' are critical for efficient editing in vitro.
Backus JW; Smith HC
Biochim Biophys Acta; 1994 Jan; 1217(1):65-73. PubMed ID: 8286418
[TBL] [Abstract][Full Text] [Related]
46. RNA editing: exploring one mode with apolipoprotein B mRNA.
Chan L
Bioessays; 1993 Jan; 15(1):33-41. PubMed ID: 8466474
[TBL] [Abstract][Full Text] [Related]
47. A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity.
Anant S; Martin SA; Yu H; MacGinnitie AJ; Devaney E; Davidson NO
Mol Biochem Parasitol; 1997 Sep; 88(1-2):105-14. PubMed ID: 9274872
[TBL] [Abstract][Full Text] [Related]
48. Apobec-1 interacts with a 65-kDa complementing protein to edit apolipoprotein-B mRNA in vitro.
Mehta A; Banerjee S; Driscoll DM
J Biol Chem; 1996 Nov; 271(45):28294-9. PubMed ID: 8910449
[TBL] [Abstract][Full Text] [Related]
49. Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity.
Wang S; Kim K; Gelvez N; Chung C; Gout JF; Fixman B; Vermulst M; Chen XS
J Mol Biol; 2023 Dec; 435(24):. PubMed ID: 38708190
[TBL] [Abstract][Full Text] [Related]
50. Apolipoprotein B mRNA editing protein: a tool for dissecting lipoprotein metabolism and a potential therapeutic gene for hypercholesterolemia.
Chan L; Teng BB; Lau P
Z Gastroenterol; 1996 Jun; 34 Suppl 3():31-2. PubMed ID: 8767453
[TBL] [Abstract][Full Text] [Related]
51. Acute modulation of the extent of apoB mRNA editing and the relative rates of syntheses of apoB48 and apoB100 in cultured rat hepatocytes by osmotic and other stress stimuli.
McCahill A; Lankester DJ; Park BS; Price NT; Zammit VA
Mol Cell Biochem; 2000 May; 208(1-2):77-87. PubMed ID: 10939631
[TBL] [Abstract][Full Text] [Related]
52. The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.
Skuse GR; Cappione AJ; Sowden M; Metheny LJ; Smith HC
Nucleic Acids Res; 1996 Feb; 24(3):478-85. PubMed ID: 8602361
[TBL] [Abstract][Full Text] [Related]
53. apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein.
Anant S; MacGinnitie AJ; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14762-7. PubMed ID: 7782342
[TBL] [Abstract][Full Text] [Related]
54. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism.
Mukhopadhyay D; Plateroti M; Anant S; Nassir F; Samarut J; Davidson NO
Endocrinology; 2003 Feb; 144(2):711-9. PubMed ID: 12538634
[TBL] [Abstract][Full Text] [Related]
55. Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.
Chen Z; Eggerman TL; Patterson AP
Biochem J; 2001 Aug; 357(Pt 3):661-72. PubMed ID: 11463337
[TBL] [Abstract][Full Text] [Related]
56. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed.
Yamanaka S; Poksay KS; Balestra ME; Zeng GQ; Innerarity TL
J Biol Chem; 1994 Aug; 269(34):21725-34. PubMed ID: 8063816
[TBL] [Abstract][Full Text] [Related]
57. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
[TBL] [Abstract][Full Text] [Related]
58. Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site.
Navaratnam N; Bhattacharya S; Fujino T; Patel D; Jarmuz AL; Scott J
Cell; 1995 Apr; 81(2):187-95. PubMed ID: 7736571
[TBL] [Abstract][Full Text] [Related]
59. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
Nakamuta M; Oka K; Krushkal J; Kobayashi K; Yamamoto M; Li WH; Chan L
J Biol Chem; 1995 Jun; 270(22):13042-56. PubMed ID: 7768898
[TBL] [Abstract][Full Text] [Related]
60. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
